UA72734C2 - Vaseline-based nasal ointment for preventing inhalation allergic reactions - Google Patents

Vaseline-based nasal ointment for preventing inhalation allergic reactions Download PDF

Info

Publication number: UA72734C2
Authority: UA; Ukraine
Prior art keywords: saturated hydrocarbons; nasal ointment; allergic reactions; nasal; mixture
Prior art date: 2000-05-31

Application number

UA2000085033A

Other languages

English (en)

Ukrainian (uk)

Original Assignee

Phyt Immun Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-31

Filing date

2000-08-27

Publication date

2005-04-15

2000-08-27 Application filed by Phyt Immun Gmbh filed Critical Phyt Immun Gmbh

2005-04-15 Publication of UA72734C2 publication Critical patent/UA72734C2/uk

Links

229940100657 nasal ointment Drugs 0.000 title claims abstract description 28
206010020751 Hypersensitivity Diseases 0.000 title claims abstract description 17
229940099259 vaseline Drugs 0.000 title 1
229930195734 saturated hydrocarbon Natural products 0.000 claims abstract description 17
239000000203 mixture Substances 0.000 claims abstract description 10
238000000034 method Methods 0.000 claims abstract description 9
235000019271 petrolatum Nutrition 0.000 claims description 11
230000002265 prevention Effects 0.000 claims description 11
SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 6
208000035285 Allergic Seasonal Rhinitis Diseases 0.000 claims description 5
206010039085 Rhinitis allergic Diseases 0.000 claims description 5
239000000654 additive Substances 0.000 claims description 5
201000010105 allergic rhinitis Diseases 0.000 claims description 5
239000002674 ointment Substances 0.000 claims description 5
GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 4
235000004866 D-panthenol Nutrition 0.000 claims description 4
239000011703 D-panthenol Substances 0.000 claims description 4
POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 4
208000030961 allergic reaction Diseases 0.000 claims description 4
125000004432 carbon atom Chemical group C* 0.000 claims description 4
239000000284 extract Substances 0.000 claims description 4
MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 claims description 3
229940023735 panthenyl ethyl ether Drugs 0.000 claims description 3
230000035699 permeability Effects 0.000 claims description 3
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
IFYVAPPYWOMVDP-ZDUSSCGKSA-N 3-[[(2r)-2,4-diacetyloxy-3,3-dimethylbutanoyl]amino]propyl acetate Chemical compound CC(=O)OCCCNC(=O)[C@H](OC(C)=O)C(C)(C)COC(C)=O IFYVAPPYWOMVDP-ZDUSSCGKSA-N 0.000 claims description 2
AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 claims description 2
POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 2
235000019489 Almond oil Nutrition 0.000 claims description 2
235000003880 Calendula Nutrition 0.000 claims description 2
240000001432 Calendula officinalis Species 0.000 claims description 2
235000007866 Chamaemelum nobile Nutrition 0.000 claims description 2
GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 2
240000000950 Hippophae rhamnoides Species 0.000 claims description 2
235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 2
239000004166 Lanolin Substances 0.000 claims description 2
244000042664 Matricaria chamomilla Species 0.000 claims description 2
235000007232 Matricaria chamomilla Nutrition 0.000 claims description 2
229960000458 allantoin Drugs 0.000 claims description 2
239000008168 almond oil Substances 0.000 claims description 2
235000021302 avocado oil Nutrition 0.000 claims description 2
239000008163 avocado oil Substances 0.000 claims description 2
229960003949 dexpanthenol Drugs 0.000 claims description 2
230000008014 freezing Effects 0.000 claims description 2
238000007710 freezing Methods 0.000 claims description 2
235000019388 lanolin Nutrition 0.000 claims description 2
229940039717 lanolin Drugs 0.000 claims description 2
235000010445 lecithin Nutrition 0.000 claims description 2
239000000787 lecithin Substances 0.000 claims description 2
229940067606 lecithin Drugs 0.000 claims description 2
229940101267 panthenol Drugs 0.000 claims description 2
235000019161 pantothenic acid Nutrition 0.000 claims description 2
239000011713 pantothenic acid Substances 0.000 claims description 2
229940055726 pantothenic acid Drugs 0.000 claims description 2
235000020957 pantothenol Nutrition 0.000 claims description 2
239000011619 pantothenol Substances 0.000 claims description 2
229920001296 polysiloxane Polymers 0.000 claims description 2
229960003504 silicones Drugs 0.000 claims description 2
239000010497 wheat germ oil Substances 0.000 claims description 2
230000000996 additive effect Effects 0.000 claims 2
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
238000012876 topography Methods 0.000 claims 1
239000013566 allergen Substances 0.000 description 8
230000000694 effects Effects 0.000 description 6
238000006243 chemical reaction Methods 0.000 description 4
239000000428 dust Substances 0.000 description 4
210000004400 mucous membrane Anatomy 0.000 description 3
210000003800 pharynx Anatomy 0.000 description 3
230000001681 protective effect Effects 0.000 description 3
238000011282 treatment Methods 0.000 description 3
206010051841 Exposure to allergen Diseases 0.000 description 2
206010019233 Headaches Diseases 0.000 description 2
208000003251 Pruritus Diseases 0.000 description 2
208000006673 asthma Diseases 0.000 description 2
230000008901 benefit Effects 0.000 description 2
238000000586 desensitisation Methods 0.000 description 2
231100000869 headache Toxicity 0.000 description 2
230000036541 health Effects 0.000 description 2
150000002430 hydrocarbons Chemical group 0.000 description 2
230000007803 itching Effects 0.000 description 2
239000000126 substance Substances 0.000 description 2
230000008961 swelling Effects 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
230000036642 wellbeing Effects 0.000 description 2
206010011224 Cough Diseases 0.000 description 1
241000195493 Cryptophyta Species 0.000 description 1
206010052804 Drug tolerance Diseases 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
206010022998 Irritability Diseases 0.000 description 1
206010023644 Lacrimation increased Diseases 0.000 description 1
239000004264 Petrolatum Substances 0.000 description 1
241000209504 Poaceae Species 0.000 description 1
241000219100 Rhamnaceae Species 0.000 description 1
206010039101 Rhinorrhoea Diseases 0.000 description 1
208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
239000000150 Sympathomimetic Substances 0.000 description 1
208000024780 Urticaria Diseases 0.000 description 1
GMBVYJOWNGZGMU-NSHDSACASA-N [(3r)-4-(3-ethoxypropylamino)-3-hydroxy-2,2-dimethyl-4-oxobutyl] acetate Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)COC(C)=O GMBVYJOWNGZGMU-NSHDSACASA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000009471 action Effects 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
238000004378 air conditioning Methods 0.000 description 1
230000007815 allergy Effects 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
229940125715 antihistaminic agent Drugs 0.000 description 1
239000000739 antihistaminic agent Substances 0.000 description 1
230000004596 appetite loss Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
239000000969 carrier Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
239000002537 cosmetic Substances 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
206010013781 dry mouth Diseases 0.000 description 1
210000003746 feather Anatomy 0.000 description 1
235000013312 flour Nutrition 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
239000003862 glucocorticoid Substances 0.000 description 1
230000026781 habituation Effects 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
230000003053 immunization Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
206010022437 insomnia Diseases 0.000 description 1
238000009434 installation Methods 0.000 description 1
239000002085 irritant Substances 0.000 description 1
231100000021 irritant Toxicity 0.000 description 1
230000000622 irritating effect Effects 0.000 description 1
231100001032 irritation of the eye Toxicity 0.000 description 1
230000004317 lacrimation Effects 0.000 description 1
230000005923 long-lasting effect Effects 0.000 description 1
235000021266 loss of appetite Nutrition 0.000 description 1
208000019017 loss of appetite Diseases 0.000 description 1
239000002075 main ingredient Substances 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
208000010753 nasal discharge Diseases 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
229940114156 panthenyl ethyl ether acetate Drugs 0.000 description 1
229940066842 petrolatum Drugs 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
230000029058 respiratory gaseous exchange Effects 0.000 description 1
230000001932 seasonal effect Effects 0.000 description 1
230000001624 sedative effect Effects 0.000 description 1
206010041232 sneezing Diseases 0.000 description 1
230000008023 solidification Effects 0.000 description 1
238000007711 solidification Methods 0.000 description 1
230000001975 sympathomimetic effect Effects 0.000 description 1
229940064707 sympathomimetics Drugs 0.000 description 1
238000002636 symptomatic treatment Methods 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
229940037128 systemic glucocorticoids Drugs 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
238000009423 ventilation Methods 0.000 description 1
239000001993 wax Substances 0.000 description 1
230000003313 weakening effect Effects 0.000 description 1
239000002023 wood Substances 0.000 description 1
210000002268 wool Anatomy 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Otolaryngology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

UA2000085033A 2000-05-31 2000-08-27 Vaseline-based nasal ointment for preventing inhalation allergic reactions UA72734C2 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE20009841U DE20009841U1 (de)	2000-05-31	2000-05-31	Nasensalbe auf Basis von Vaselin

Publications (1)

Publication Number	Publication Date
UA72734C2 true UA72734C2 (en)	2005-04-15

Family

ID=7942316

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UA2000085033A UA72734C2 (en)	2000-05-31	2000-08-27	Vaseline-based nasal ointment for preventing inhalation allergic reactions

Country Status (19)

Country	Link
US (3)	US20030161899A1 (cs)
EP (2)	EP1159958A1 (cs)
JP (2)	JP2001342131A (cs)
KR (1)	KR20030030998A (cs)
AT (1)	ATE493112T1 (cs)
AU (1)	AU2001267504A1 (cs)
BG (1)	BG64887B1 (cs)
BR (1)	BR0003852A (cs)
CA (1)	CA2413188A1 (cs)
CZ (1)	CZ296192B6 (cs)
DE (2)	DE20009841U1 (cs)
EE (1)	EE04769B1 (cs)
HR (1)	HRP20000559A2 (cs)
HU (1)	HUP0003408A2 (cs)
PL (1)	PL198950B1 (cs)
RU (1)	RU2237468C2 (cs)
SK (1)	SK286019B6 (cs)
UA (1)	UA72734C2 (cs)
WO (1)	WO2001091719A1 (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE20009841U1 (de) *	2000-05-31	2001-10-25	Phyt-Immun GmbH, 66424 Homburg	Nasensalbe auf Basis von Vaselin
JP4614423B2 (ja) *	2004-04-30	2011-01-19	フマキラー株式会社	アレルギー性鼻炎用鼻腔用組成物
JP2006008516A (ja) *	2004-06-21	2006-01-12	Nippon Kenko Kagaku Kenkyu Center:Kk	鼻孔花粉症予防用軟膏、及び、鼻孔花粉症予防用ステック状軟膏
JP2006312635A (ja) *	2005-04-08	2006-11-16	Hinode Sangyo Kk	鼻腔壁塗布組成物
NL2001342C2 (nl) *	2008-02-20	2009-08-24	Cornelis Boegem	Balsem voor het afdekken van slijmvliezen tegen in de lucht aanwezige allergene stoffen, het gebruik van de balsem en een applicator voor de balsem.
JP5337984B2 (ja) *	2008-11-07	2013-11-06	アース製薬株式会社	鼻腔内塗布製剤及び鼻腔内におけるダレを防止する方法
WO2013049539A1 (en) *	2011-09-30	2013-04-04	Mcneil-Ppc, Inc.	A method of blocking or trapping allergens
CN112076148B (zh) *	2019-06-12	2025-01-10	陕西佰傲再生医学有限公司	鼻用抗过敏凝胶及制备方法
AU2020230306A1 (en) *	2020-09-10	2022-03-24	Dao Cheng Song	It is a method to suppress/cure hay fever. Having some moisturiser (Lip Balm, Papaw Ointment) to wax around the inner nose it can effectively suppress hay fever. This invention is a guide for any manufacture interested in creating a product that consists of a similar type of ingredients and creating a specialised medical item, designed a sole purpose for coping hay fever.
JP7074388B1 (ja) *	2022-01-25	2022-05-24	株式会社オフィスシステムサービス	鼻用の外用剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2095092A (en) *	1936-02-21	1937-10-05	Clorox Chemical Co	Ointment
DE3010572C2 (de) *	1980-03-19	1982-05-06	Süess, Hans R., Dr., Starrkirch	Hautpflege- und Hautschutzpräparate
DE3416209A1 (de) *	1984-05-02	1985-11-21	Mohamed Roshdy Dr Ismail	Zubereitungen zur behandlung von augen
ATE84968T1 (de) *	1987-11-13	1993-02-15	Asta Medica Ag	Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge.
ES2149761T3 (es) *	1990-04-25	2000-11-16	Nissan Chemical Ind Ltd	Derivado de piridazinona.
DE4117887C2 (de) *	1990-06-09	1993-12-16	Siegfried Rochler	Verwendung von pharmazeutisch/kosmetisch als Vaselin definierten gesättigten Kohlenwasserstoffen als Nasensalbe zur Prophylaxe von inhalationsallergischen Reaktionen
EP0529499A1 (de) *	1991-08-22	1993-03-03	Hoechst Aktiengesellschaft	Pharmazeutische Zusammensetzungen enthaltend Bradykinin-Antagonisten zur lokalen Anwendung an Nase und Auge
RU2038071C1 (ru) *	1992-12-15	1995-06-27	Дейгин Владислав Исакович	Крем для кожи лица
DE4438589A1 (de) *	1994-10-28	1995-03-23	Reingard Dr Muenster	Nasentherapeutikum
DE19544905A1 (de) *	1995-12-01	1997-06-05	Robugen Gmbh	Verfahren zur Herstellung von Pflanzenextrakten
US5972327A (en) *	1997-10-22	1999-10-26	Lin; Matthew M.	Method of treating allergic rhinitis by delivering medication via the nasal vestibules
JPH11246416A (ja) *	1998-03-05	1999-09-14	Nof Corp	点鼻用添加剤及び点鼻薬
DE20002395U1 (de) *	2000-02-13	2000-05-25	Febena Pharma GmbH, 50825 Köln	Creme, insbesondere zur äußeren Anwendung auf der Nasenhaut
DE20009841U1 (de) *	2000-05-31	2001-10-25	Phyt-Immun GmbH, 66424 Homburg	Nasensalbe auf Basis von Vaselin

2000
- 2000-05-31 DE DE20009841U patent/DE20009841U1/de not_active Expired - Lifetime
- 2000-08-22 CZ CZ20003062A patent/CZ296192B6/cs not_active IP Right Cessation
- 2000-08-24 SK SK1281-2000A patent/SK286019B6/sk not_active IP Right Cessation
- 2000-08-24 EE EEP200000375A patent/EE04769B1/xx not_active IP Right Cessation
- 2000-08-25 HU HU0003408A patent/HUP0003408A2/hu unknown
- 2000-08-25 PL PL342179A patent/PL198950B1/pl not_active IP Right Cessation
- 2000-08-25 RU RU2000122478/15A patent/RU2237468C2/ru not_active IP Right Cessation
- 2000-08-27 UA UA2000085033A patent/UA72734C2/uk unknown
- 2000-08-28 BG BG104714A patent/BG64887B1/bg unknown
- 2000-08-28 JP JP2000257825A patent/JP2001342131A/ja active Pending
- 2000-08-28 HR HR20000559A patent/HRP20000559A2/hr not_active Application Discontinuation
- 2000-08-28 BR BR0003852-0A patent/BR0003852A/pt not_active IP Right Cessation
- 2000-08-29 EP EP00118143A patent/EP1159958A1/de not_active Withdrawn
2001
- 2001-05-31 EP EP01945223A patent/EP1286657B1/de not_active Expired - Lifetime
- 2001-05-31 KR KR1020027016096A patent/KR20030030998A/ko not_active Ceased
- 2001-05-31 CA CA002413188A patent/CA2413188A1/en not_active Abandoned
- 2001-05-31 DE DE50115757T patent/DE50115757D1/de not_active Expired - Lifetime
- 2001-05-31 AT AT01945223T patent/ATE493112T1/de active
- 2001-05-31 US US10/296,934 patent/US20030161899A1/en not_active Abandoned
- 2001-05-31 AU AU2001267504A patent/AU2001267504A1/en not_active Abandoned
- 2001-05-31 WO PCT/EP2001/006197 patent/WO2001091719A1/de not_active Ceased
2002
- 2002-02-14 US US10/077,259 patent/US20020082305A1/en not_active Abandoned
2006
- 2006-05-29 JP JP2006148823A patent/JP2006316063A/ja active Pending
2012
- 2012-05-14 US US13/470,541 patent/US20120308671A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1159958A1 (de)	2001-12-05
ATE493112T1 (de)	2011-01-15
KR20030030998A (ko)	2003-04-18
SK12812000A3 (sk)	2001-12-03
PL342179A1 (en)	2001-12-03
BR0003852A (pt)	2002-07-23
US20030161899A1 (en)	2003-08-28
PL198950B1 (pl)	2008-08-29
EP1286657A1 (de)	2003-03-05
WO2001091719A1 (de)	2001-12-06
HU0003408D0 (en)	2000-08-25
US20020082305A1 (en)	2002-06-27
JP2001342131A (ja)	2001-12-11
US20120308671A1 (en)	2012-12-06
EP1286657B1 (de)	2010-12-29
EE200000375A (et)	2002-02-15
BG104714A (en)	2002-05-31
DE20009841U1 (de)	2001-10-25
SK286019B6 (sk)	2008-01-07
CA2413188A1 (en)	2001-12-06
CZ296192B6 (cs)	2006-02-15
HUP0003408A2 (en)	2002-09-28
HRP20000559A2 (en)	2001-12-31
JP2006316063A (ja)	2006-11-24
DE50115757D1 (de)	2011-02-10
CZ20003062A3 (cs)	2002-01-16
BG64887B1 (bg)	2006-08-31
EE04769B1 (et)	2007-02-15
RU2237468C2 (ru)	2004-10-10
AU2001267504A1 (en)	2001-12-11

Publication	Publication Date	Title
US20120308671A1 (en)	2012-12-06	Nasal ointment based on white petroleum jelly
DE69926377D1 (de)	2005-09-01	Orale flüssige mucoadhäsive zusammensetzungen
DE69904057D1 (de)	2003-01-02	Orale flüssige mucoadhäsive zusammensetzungen
ES2360290T3 (es)	2011-06-02	Composición queratolitica con propiedades antialergicas y antiinflamatorias.
US20030031730A1 (en)	2003-02-13	Nasal passage cleaning composition
MXPA03007748A (es)	2004-03-16	Composiciones que destruyen virus.
US20240180885A1 (en)	2024-06-06	Composition and delivery method for treatment of pharyngeal tonsil
US5516765A (en)	1996-05-14	Therapeutic method for the treatment or prevention of snoring
US20090258946A1 (en)	2009-10-15	Electrostatically charged nasal application multipurpose products and method
FR3015291A1 (fr)	2015-06-26	Composition antiprurigineuse
JP2001240547A (ja)	2001-09-04	花粉症抑制剤
ATE226429T1 (de)	2002-11-15	Orale flüssige mucoadhäsive zusammensetzungen
US378504A (en)	1888-02-28	Catarrh remedy
JP2005314311A (ja)	2005-11-10	アレルギー性鼻炎用鼻腔用組成物
JP6586450B2 (ja)	2019-10-02	アレルゲン抗体およびそれを有する組成物
GRIESMAN	1949	Study on the Range of Usefulness of a New Dual Form Intranasal Medicament
EP2875821A1 (en)	2015-05-27	Natural liquid composition against infections
Belanger	2000	The common cold [Ask your pharmacist]